UroGen Pharma Appoints David Lin as New Chief Commercial Officer

Go back to UroGen Pharma Appoints David Lin as New Chief Commercial Officer
(NASDAQ: URGN) Delayed: 42.24 -2.76 (6.13%)
Previous Close $45.00    52 Week High
Open $44.25    52 Week Low
Day High $44.48    P/E N/A 
Day Low $41.85    EPS
Volume 688,668